MeSH 搜索器

Neuroleptic Malignant Syndrome

A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72)
推出的年份: 1986(1985)
副标题
树号: C10.228.140.079.737, C10.720.737, C25.723.705.600
MeSH 单一 ID: D009459
进入的组:
  • Neuroleptic Malignant Syndromes
  • Syndrome, Neuroleptic Malignant
  • Syndromes, Neuroleptic Malignant
  • NMS (Neuroleptic Malignant Syndrome)
  • NMSs (Neuroleptic Malignant Syndrome)
  • Neuroleptic-Induced Neuroleptic Malignant Syndrome
  • Neuroleptic Induced Neuroleptic Malignant Syndrome
  • Neuroleptic-Malignant Syndrome, Neuroleptic Induced
  • Neuroleptic Malignant Syndrome, Neuroleptic Induced
早前的内容:
  • Basal Ganglia Diseases (1979-1984)
  • Fever (1966-1984)
  • Malignant Hyperthermia (1973-1984)
  • Muscle Rigidity (1972-1984)
  • Tranquilizing Agents, Major (1975-1984)

留言 (0)

沒有登入
gif